Q3 2024 Holdings
Filed 2024-11-14 | 42 holdings | $642.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $86.7M | 3,006,980 | 13.5% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $52.8M | 1,835,200 | 8.2% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $52.6M | 1,198,000 | 8.2% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $47.8M | 1,746,667 | 7.4% |
| Arrivent Biopharma Inc(AVBP) | COM | 04272N102 | $46.4M | 1,976,387 | 7.2% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $32.2M | 2,012,052 | 5.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $31.9M | 436,820 | 5.0% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $27.9M | 12,171,513 | 4.3% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $23.0M | 1,115,000 | 3.6% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $21.1M | 2,425,000 | 3.3% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $19.8M | 870,000 | 3.1% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $19.0M | 1,422,224 | 3.0% |
| Insmed Inc(INSM)Call | COM PAR $.01 | 457669307 | $18.3M | 250,000 | 2.8% |
| Mind Medicine Mindmed Inc(BRD1EUR) | COM NEW | 60255C885 | $17.2M | 3,018,000 | 2.7% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $14.1M | 1,305,000 | 2.2% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $14.1M | 552,000 | 2.2% |
| Pharvaris N V(PHVS) | COM | N69605108 | $11.5M | 620,470 | 1.8% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $9.4M | 262,726 | 1.5% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $9.2M | 4,572,222 | 1.4% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $9.1M | 9,187,883 | 1.4% |
| Allovir Inc | COM | 019818103 | $9.1M | 11,202,000 | 1.4% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $8.7M | 1,093,503 | 1.4% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $7.5M | 130,000 | 1.2% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $7.3M | 600,000 | 1.1% |
| Regulus Therapeutics Inc(RGLS) | COM | 75915K309 | $6.7M | 4,263,701 | 1.0% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $5.2M | 2,391,114 | 0.8% |
| Tenaya Therapeutics Inc(TNYA) | COM | 87990A106 | $5.0M | 2,576,200 | 0.8% |
| Cybin Inc(HELP) | COM | 23256X407 | $4.4M | 489,596 | 0.7% |
| Reneo Pharmaceuticals Inc(RPHM) | COM | 75974E103 | $3.8M | 2,250,000 | 0.6% |
| Unicycive Therapeutics Inc | COM | 90466Y103 | $3.5M | 8,559,000 | 0.5% |
| Pepgen Inc(PEPG) | COM | 713317105 | $3.2M | 376,117 | 0.5% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $2.6M | 250,000 | 0.4% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $2.6M | 594,000 | 0.4% |
| Annexon Inc(ANNX) | COM | 03589W102 | $2.4M | 400,000 | 0.4% |
| Mersana Therapeutics Inc | COM | 59045L106 | $1.9M | 992,000 | 0.3% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $1.1M | 666,825 | 0.2% |
| Aerovate Therapeutics Inc | COM | 008064107 | $972.8K | 465,440 | 0.2% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 07/07/202 | 67080N119 | $715.2K | 312,336 | 0.1% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $638.9K | 176,000 | 0.1% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $629.4K | 15,000 | 0.1% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $586.9K | 292,000 | 0.1% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $542.4K | 120,000 | 0.1% |